Vericiguat attenuates high phosphate-induced vascular smooth muscle cell calcification through the PKG/VASP/NF-kB/NLRP3 pathway

Abstract Background Vascular calcification is a common pathological feature of chronic kidney disease, diabetes, and atherosclerotic cardiovascular disease and is closely associated with arterial stiffness and adverse cardiovascular outcomes. High extracellular phosphate is a major driver of vascular smooth muscle cell (VSMC) calcification, promoting osteogenic phenotypic switching, inflammatory activation, and mineral deposition. Vericiguat, an oral soluble guanylate cyclase (sGC) stimulator approved for heart failure with reduced ejection fraction, enhances cyclic guanosine monophosphate signaling and exerts anti-inflammatory and cytoprotective effects. However, its effect on high phosphate-induced vascular calcification remains unclear. Methods A7r5 cells were exposed to 10 mmol/L β-glycerophosphate (β-GP) to establish an in vitro calcification model. Vericiguat was administered at 100 µmol/L. The PKG inhibitor Rp-8-Br-PET-cGMPS was used at 10 µM to evaluate the involvement of PKG signaling. Calcification, phenotypic switching, and inflammatory signaling were assessed by Alizarin Red S staining, calcium content assay, Western blotting, and ELISA. Results High phosphate significantly increased mineral deposition and calcium content in A7r5 cells. It also decreased the contractile markers α-smooth muscle actin (α-SMA) and SM22α while increasing the osteogenic markers bone morphogenetic protein 2 (BMP2) and runt-related transcription factor 2 (RUNX2). Vericiguat markedly attenuated these changes, indicating inhibition of calcification and phenotypic switching. Mechanistically, vericiguat increased the p-VASP (Ser239)/VASP ratio and reduced the p-IkBα/IkBα ratio, suggesting activation of PKG/VASP signaling and suppression of NF-kB activity. Pharmacological inhibition of PKG partially abolished the protective effects of vericiguat on calcification and osteogenic transdifferentiation. Vericiguat also suppressed high phosphate-induced activation of the NLRP3 inflammasome, as shown by reduced expression of NLRP3, ASC, p-Caspase-1, and IL-1β, together with decreased IL-1β secretion. These anti-inflammatory effects were partially reversed by PKG inhibition. Conclusions Vericiguat attenuates high phosphate-induced VSMC calcification and inflammatory activation, at least in part through the PKG/VASP/NF-kB/NLRP3 signaling pathway. Vericiguat may represent a potential therapeutic strategy for phosphate-driven vascular calcification.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-13
DOI
https://doi.org/10.21203/rs.3.rs-11513531/v1
Primary Topic
Parathyroid Disorders and Treatments
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Vericiguat attenuates high phosphate-induced vascular smooth muscle cell calcification through the PKG/VASP/NF-kB/NLRP3 pathway

Lixia Bu, Shaojie Li, Xiwang Hao, Mingfeng Ma et al.
2 links
Research Square
Parathyroid Disorders and Treatments
preprint

Vericiguat attenuates high phosphate-induced vascular smooth muscle cell calcification through the PKG/VASP/NF-kB/NLRP3 pathway

Lixia Bu, Shaojie Li, Xiwang Hao, Mingfeng Ma, Ying Zhao, Haifeng Li
preprint en

Abstract

Abstract Background Vascular calcification is a common pathological feature of chronic kidney disease, diabetes, and atherosclerotic cardiovascular disease and is closely associated with arterial stiffness and adverse cardiovascular outcomes. High extracellular phosphate is a major driver of vascular smooth muscle cell (VSMC) calcification, promoting osteogenic phenotypic switching, inflammatory activation, and mineral deposition. Vericiguat, an oral soluble guanylate cyclase (sGC) stimulator approved for heart failure with reduced ejection fraction, enhances cyclic guanosine monophosphate signaling and exerts anti-inflammatory and cytoprotective effects. However, its effect on high phosphate-induced vascular calcification remains unclear. Methods A7r5 cells were exposed to 10 mmol/L β-glycerophosphate (β-GP) to establish an in vitro calcification model. Vericiguat was administered at 100 µmol/L. The PKG inhibitor Rp-8-Br-PET-cGMPS was used at 10 µM to evaluate the involvement of PKG signaling. Calcification, phenotypic switching, and inflammatory signaling were assessed by Alizarin Red S staining, calcium content assay, Western blotting, and ELISA. Results High phosphate significantly increased mineral deposition and calcium content in A7r5 cells. It also decreased the contractile markers α-smooth muscle actin (α-SMA) and SM22α while increasing the osteogenic markers bone morphogenetic protein 2 (BMP2) and runt-related transcription factor 2 (RUNX2). Vericiguat markedly attenuated these changes, indicating inhibition of calcification and phenotypic switching. Mechanistically, vericiguat increased the p-VASP (Ser239)/VASP ratio and reduced the p-IkBα/IkBα ratio, suggesting activation of PKG/VASP signaling and suppression of NF-kB activity. Pharmacological inhibition of PKG partially abolished the protective effects of vericiguat on calcification and osteogenic transdifferentiation. Vericiguat also suppressed high phosphate-induced activation of the NLRP3 inflammasome, as shown by reduced expression of NLRP3, ASC, p-Caspase-1, and IL-1β, together with decreased IL-1β secretion. These anti-inflammatory effects were partially reversed by PKG inhibition. Conclusions Vericiguat attenuates high phosphate-induced VSMC calcification and inflammatory activation, at least in part through the PKG/VASP/NF-kB/NLRP3 signaling pathway. Vericiguat may represent a potential therapeutic strategy for phosphate-driven vascular calcification.

Research Square
Shanxi Medical University (CN), Shanxi Fenyang Hospital (CN)
Good health and well-being
Parathyroid Disorders and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon